171 related articles for article (PubMed ID: 25177232)
21. Amino acid utilisation and deamination of glutamine and asparagine by Helicobacter pylori.
Stark RM; Suleiman MS; Hassan IJ; Greenman J; Millar MR
J Med Microbiol; 1997 Sep; 46(9):793-800. PubMed ID: 9291892
[TBL] [Abstract][Full Text] [Related]
22. Design and Characterization of Erwinia Chrysanthemi l-Asparaginase Variants with Diminished l-Glutaminase Activity.
Nguyen HA; Su Y; Lavie A
J Biol Chem; 2016 Aug; 291(34):17664-76. PubMed ID: 27354283
[TBL] [Abstract][Full Text] [Related]
23. Multiple adaptive mechanisms affect asparagine synthetase substrate availability in asparaginase-resistant MOLT-4 human leukaemia cells.
Aslanian AM; Kilberg MS
Biochem J; 2001 Aug; 358(Pt 1):59-67. PubMed ID: 11485552
[TBL] [Abstract][Full Text] [Related]
24. Asparagine synthetase as a causal, predictive biomarker for L-asparaginase activity in ovarian cancer cells.
Lorenzi PL; Reinhold WC; Rudelius M; Gunsior M; Shankavaram U; Bussey KJ; Scherf U; Eichler GS; Martin SE; Chin K; Gray JW; Kohn EC; Horak ID; Von Hoff DD; Raffeld M; Goldsmith PK; Caplen NJ; Weinstein JN
Mol Cancer Ther; 2006 Nov; 5(11):2613-23. PubMed ID: 17088436
[TBL] [Abstract][Full Text] [Related]
25. In silico engineering of L-asparaginase to have reduced glutaminase side activity for effective treatment of acute lymphoblastic leukemia.
Ln R; Doble M; Rekha VP; Pulicherla KK
J Pediatr Hematol Oncol; 2011 Dec; 33(8):617-21. PubMed ID: 22042278
[TBL] [Abstract][Full Text] [Related]
26. Asparaginase in the treatment of non-ALL hematologic malignancies.
Emadi A; Zokaee H; Sausville EA
Cancer Chemother Pharmacol; 2014 May; 73(5):875-83. PubMed ID: 24515335
[TBL] [Abstract][Full Text] [Related]
27. Cerebrospinal fluid asparagine depletion during pegylated asparaginase therapy in children with acute lymphoblastic leukaemia.
Henriksen LT; Nersting J; Raja RA; Frandsen TL; Rosthøj S; Schrøder H; Albertsen BK;
Br J Haematol; 2014 Jul; 166(2):213-20. PubMed ID: 24702187
[TBL] [Abstract][Full Text] [Related]
28. A clinically attainable dose of L-asparaginase targets glutamine addiction in lymphoid cell lines.
Sugimoto K; Suzuki HI; Fujimura T; Ono A; Kaga N; Isobe Y; Sasaki M; Taka H; Miyazono K; Komatsu N
Cancer Sci; 2015 Nov; 106(11):1534-43. PubMed ID: 26331698
[TBL] [Abstract][Full Text] [Related]
29. Structure and function of the thermostable L-asparaginase from Thermococcus kodakarensis.
Guo J; Coker AR; Wood SP; Cooper JB; Chohan SM; Rashid N; Akhtar M
Acta Crystallogr D Struct Biol; 2017 Nov; 73(Pt 11):889-895. PubMed ID: 29095161
[TBL] [Abstract][Full Text] [Related]
30. ω-Amidase: an underappreciated, but important enzyme in L-glutamine and L-asparagine metabolism; relevance to sulfur and nitrogen metabolism, tumor biology and hyperammonemic diseases.
Cooper AJ; Shurubor YI; Dorai T; Pinto JT; Isakova EP; Deryabina YI; Denton TT; Krasnikov BF
Amino Acids; 2016 Jan; 48(1):1-20. PubMed ID: 26259930
[TBL] [Abstract][Full Text] [Related]
31. Monitoring of asparaginase activity and asparagine levels in children on different asparaginase preparations.
Boos J; Werber G; Ahlke E; Schulze-Westhoff P; Nowak-Göttl U; Würthwein G; Verspohl EJ; Ritter J; Jürgens H
Eur J Cancer; 1996 Aug; 32A(9):1544-50. PubMed ID: 8911116
[TBL] [Abstract][Full Text] [Related]
32. [Research on the pharmacokinetics and pharmacodynamics of L-asparaginase during its treatment of childhood acute lymphoblastic leukemia].
Chen FX; Cui YQ; Wu ZL; Ye TZ; Lai YH; Zou YW; Lu CY; Guan JM; Wei FG; Zhang H
Zhonghua Xue Ye Xue Za Zhi; 2005 Feb; 26(2):100-2. PubMed ID: 15921627
[TBL] [Abstract][Full Text] [Related]
33. Structural and functional insights into Erwinia carotovora L-asparaginase.
Papageorgiou AC; Posypanova GA; Andersson CS; Sokolov NN; Krasotkina J
FEBS J; 2008 Sep; 275(17):4306-16. PubMed ID: 18647344
[TBL] [Abstract][Full Text] [Related]
34. Structural Insight into Substrate Selectivity of Erwinia chrysanthemi L-asparaginase.
Nguyen HA; Su Y; Lavie A
Biochemistry; 2016 Mar; 55(8):1246-53. PubMed ID: 26855287
[TBL] [Abstract][Full Text] [Related]
35. Purification and characterization of glutaminase-free L-asparaginase from Pectobacterium carotovorum MTCC 1428.
Kumar S; Venkata Dasu V; Pakshirajan K
Bioresour Technol; 2011 Jan; 102(2):2077-82. PubMed ID: 20832300
[TBL] [Abstract][Full Text] [Related]
36. Cloning and characterization of Halomonas elongata L-asparaginase, a promising chemotherapeutic agent.
Ghasemi A; Asad S; Kabiri M; Dabirmanesh B
Appl Microbiol Biotechnol; 2017 Oct; 101(19):7227-7238. PubMed ID: 28801829
[TBL] [Abstract][Full Text] [Related]
37. Role of glutamine depletion in directing tissue-specific nutrient stress responses to L-asparaginase.
Reinert RB; Oberle LM; Wek SA; Bunpo P; Wang XP; Mileva I; Goodwin LO; Aldrich CJ; Durden DL; McNurlan MA; Wek RC; Anthony TG
J Biol Chem; 2006 Oct; 281(42):31222-33. PubMed ID: 16931516
[TBL] [Abstract][Full Text] [Related]
38. Bacterial l-asparaginases for cancer therapy: Current knowledge and future perspectives.
Ghasemian A; Al-Marzoqi AH; Al-Abodi HR; Alghanimi YK; Kadhum SA; Shokouhi Mostafavi SK; Fattahi A
J Cell Physiol; 2019 Nov; 234(11):19271-19279. PubMed ID: 30993718
[TBL] [Abstract][Full Text] [Related]
39. A pharmacological study on pegylated asparaginase used in front-line treatment of children with acute lymphoblastic leukemia.
Rizzari C; Citterio M; Zucchetti M; Conter V; Chiesa R; Colombini A; Malguzzi S; Silvestri D; D'Incalci M
Haematologica; 2006 Jan; 91(1):24-31. PubMed ID: 16434367
[TBL] [Abstract][Full Text] [Related]
40. Low expression of asparagine synthetase in lymphoid blasts precludes its role in sensitivity to L-asparaginase.
Hermanova I; Zaliova M; Trka J; Starkova J
Exp Hematol; 2012 Aug; 40(8):657-65. PubMed ID: 22542578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]